中国医院药学服务价值链构建研究——基于广东省综合性医院的综述
Research on the Construction of Pharmaceutical Service Value Chain in Chinese Hospitals—A Review Based on Comprehensive Hospitals in Guangdong Province
DOI: 10.12677/ssem.2025.146110, PDF,   
作者: 林 佳:广州医药股份有限公司,广东 广州;王 尧:南方医科大学珠江医院,广东 广州;吴启毓:广东省人民医院,广东 广州;玛丽亚·若泽·马德拉:葡萄牙里斯本大学学院,葡萄牙 里斯本
关键词: 药学服务价值链管理以患者为中心医院管理新医改Pharmaceutical Services Value Chain Management Patient-Centered Care Hospital Management New Healthcare Reform
摘要: 随着新医改政策的持续推进,中国医院药学部门由传统的利润中心逐渐转变为以患者为中心的服务职能部门。如何在转型过程中构建高效、可持续发展的药学服务价值链,成为亟待解决的重要课题。本文基于价值链理论,综述了国内外药学服务价值链的研究进展,分析了广东省综合性医院药学服务的现状及存在的问题,包括药学服务模式单一、增值环节缺失、价值链协同不足等。结合现有文献与实践探索,本文提出了以患者需求为导向,优化药学服务功能链条,强化供应链与协作链整合,提升信息链管理水平,构建以患者为中心的医院药学服务新价值链体系。未来,需加强政策支持与技术创新,助力医院药学部门在后疫情时代实现高质量发展。
Abstract: With the ongoing advancement of China’s healthcare reform, hospital pharmacy departments are shifting from traditional profit centers to patient-centered service providers. Constructing an efficient and sustainable value chain for pharmaceutical services has become a critical issue. Based on value chain theory, this paper reviews the domestic and international research progress on hospital pharmaceutical service value chains, analyzes the current situation and challenges faced by comprehensive hospitals in Guangdong Province, including single service models, lack of value-added links, and insufficient chain collaboration. It further proposes optimization strategies such as expanding service functions, strengthening supply chain and collaboration chain integration, enhancing information chain management, and building a patient-centered pharmaceutical service value chain system. In the future, more policy support and technological innovation are needed to promote high-quality development of hospital pharmacy services in the post-pandemic era.
文章引用:林佳, 王尧, 吴启毓, 玛丽亚·若泽·马德拉. 中国医院药学服务价值链构建研究——基于广东省综合性医院的综述 [J]. 服务科学和管理, 2025, 14(6): 875-881. https://doi.org/10.12677/ssem.2025.146110

参考文献

[1] 李静, 郭斌斌, 路伟. 公立医院“成本病”与医疗负担——兼论“药品零加成”政策的影响[J]. 南方经济, 2022(9): 59-74.
[2] ASHP Guidelines on a Standardized Method for Pharmaceutical Care (1996) American Society of Health-System Pharmacists. American Journal of Health-System Pharmacy, 53, 1713-1716.
[3] Hepler, C.D. and Strand, L.M. (1990) Opportunities and Responsibilities in Pharmaceutical Care. American Journal of Health-System Pharmacy, 47, 533-543. [Google Scholar] [CrossRef
[4] Porter, M.E. (1985) Competitive Advantage: Creating and Sustaining Superior Performance. Free Press.
[5] Gereffi, G., Humphrey, J. and Sturgeon, T. (2005) The Governance of Global Value Chains. Review of International Political Economy, 12, 78-104. [Google Scholar] [CrossRef
[6] Kaplinsky, R. and Morris, M. (2001) A Handbook for Value Chain Research. IDRC.
[7] Lounsbery, J.L., Green, C.G., Bennett, M.S. and Pedersen, C.A. (2009) Evaluation of Pharmacists’ Barriers to the Implementation of Medication Therapy Management Services. Journal of the American Pharmacists Association, 49, 51-58. [Google Scholar] [CrossRef] [PubMed]
[8] Hashimoto, H., Ikegami, N., Shibuya, K., Izumida, N., Noguchi, H., Yasunaga, H., et al. (2011) Cost Containment and Quality of Care in Japan: Is There a Trade-Off? The Lancet, 378, 1174-1182. [Google Scholar] [CrossRef] [PubMed]
[9] Vogler, S., Zimmermann, N., Leopold, C. and De Joncheere, K. (2011) Pharmaceutical Policies in European Countries in Response to the Global Financial Crisis. Southern Med Review, 4, 22-32. [Google Scholar] [CrossRef] [PubMed]
[10] 崔敏, 刘晓琰, 逄晓云, 等. 临床药师实施药学服务切入点分析[J]. 药学服务与研究, 2015, 15(4): 318-320.
[11] 曹莉, 唐雪花, 李丽. 重点监控药品点评模式促进合理用药持续改进[J]. 新疆医学, 2019, 49(9): 950-952.
[12] 龚辉, 李晨, 单青, 等. 基于综合药物管理评价的老年患者药物相关问题的药学服务模式探索[J]. 中国药房, 2023, 34(17): 2162-2166.